Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lexaria Bioscience Corp (LXX.CN)

Lexaria Bioscience Corp (LXX.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 54,123
  • Shares Outstanding, K 80,721
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 4.07
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 15.93
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings -0.01 on 11/30/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.400 +62.50%
on 01/08/20
0.660 -1.52%
on 01/16/20
+0.150 (+30.00%)
since 12/17/19
3-Month
0.400 +62.50%
on 01/08/20
0.990 -34.34%
on 10/25/19
-0.220 (-25.29%)
since 10/17/19
52-Week
0.400 +62.50%
on 01/08/20
2.170 -70.05%
on 01/18/19
-1.460 (-69.19%)
since 01/17/19

Most Recent Stories

More News
Lexaria Bioscience Corp. and Cannadips CBD Announce Definitive Technology Licensing agreement for CBD Oral Pouch & Dip Category

KELOWNA, BC / ACCESSWIRE / January 14, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has reached a...

LXRP : 0.5140 (+2.80%)
LXX.CN : 0.650 (+3.17%)
Lexaria Provides Strategic Update from CEO

KELOWNA, BC / ACCESSWIRE / January 9, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces the following strategic...

LXRP : 0.5140 (+2.80%)
LXX.CN : 0.650 (+3.17%)
Lexaria Provides Strategic Update from CEO

(via TheNewswire)

LXRP : 0.5140 (+2.80%)
LXX.CN : 0.650 (+3.17%)
Lexaria Awards Options

(via TheNewswire)

LXRP : 0.5140 (+2.80%)
LXX.CN : 0.650 (+3.17%)
Lexaria Announces 2nd Tranche Closing of Non-Brokered Private Placement

(via TheNewswire)

LXRP : 0.5140 (+2.80%)
LXX.CN : 0.650 (+3.17%)
Lexaria's Technology Now Works in Less Than 10 Minutes

(via TheNewswire)

LXRP : 0.5140 (+2.80%)
LXX.CN : 0.650 (+3.17%)
Lexaria Announces Closing of Non-Brokered Private Placement

(via TheNewswire)

LXRP : 0.5140 (+2.80%)
LXX.CN : 0.650 (+3.17%)
Lexaria Awards Options

(via TheNewswire)

LXRP : 0.5140 (+2.80%)
LXX.CN : 0.650 (+3.17%)
Lexaria Bioscience Appoints Gregg Smith as Senior Advisor

KELOWNA, BC / ACCESSWIRE / November 5, 2019 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is very pleased to announce the...

LXRP : 0.5140 (+2.80%)
LXX.CN : 0.650 (+3.17%)
Lexaria Bioscience Appoints Gregg Smith as Senior Advisor Evolution VC Partners participates in equity financing

(via TheNewswire)

LXRP : 0.5140 (+2.80%)
LXX.CN : 0.650 (+3.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 0.663
1st Resistance Point 0.657
Last Price 0.650
1st Support Level 0.637
2nd Support Level 0.623

See More

52-Week High 2.170
Fibonacci 61.8% 1.494
Fibonacci 50% 1.285
Fibonacci 38.2% 1.076
Last Price 0.650
52-Week Low 0.400

See More

Business Summary

Lexaria Bioscience Corp is a food science company. The company's food sciences activities include the development of the proprietary nutrient infusion technologies for the production of superfoods, and the production of enhanced food products under two consumer product brands, ViPova and Lexaria Energy....

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar